Importantly, a reduced plasma APOA2 protein level was previously found to be related to cognitive decline in normal aging subjects during a 2-year follow-up period (Song et al., 2012); this suggests that the relatively low APOA2 expression in the MCI group were predisposed to further decline in their cognitive function. The gene discussed is APOA2; the disease is Mental deterioration.